HUGE: Rule massively financially incentivizing hospitals to poison and kill Covid patients found. Save and share aggressively.

GibMessenger
Tue, 04 Jan 2022 11:24:28 +0000
Depopulation & WW3

barnhardt.biz

HUGE: Rule massively financially incentivizing hospitals to poison and kill...

Once again, a private person using simple web searching skills and the ability to read and comprehend simple English has blown the lid off of YET ANOTHER facet of the Covidic Genocide. Via Nurse Claire, this is a twitter thread of a lady who has just a few hundred followers, so I’m going to copy-paste the text of her thread here to safeguard against censorship.

She has found the rule directly financially incentivizing doctors and hospitals to withhold treatment and actively poison and murder Covid patients. If you’re wondering why hospitals are in lock-step in their murderous “treatment protocols”, it is because the psychopaths in charge are after one thing: MONEY. And the beta-narcissists under them follow along in order to maintain their career tracks and incomes. But the thing these people all have in common is a total lack of human empathy and complete absence of conscience. Human beings are nothing more than meat bags to be turned into cash flow by any means necessary, including conscious, premeditated murder, as you will see below.

It will be VERY interesting to see if the new “Pfizermectin” drug – a drug which has the same mode of action as Ivermectin, except with less efficacy AND is paired with a drug from the HIV cocktail which destroys the liver, will be added into this same scam. It will also be VERY interesting to see how the “Pfizermectin” will be priced and billed. Ivermectin is off-patent and costs pennies per dose. How much do you want to bet that the “Pfizermectin” in billed in the four-figures? And do you know the worst thing? Due to the market-poisoning effect of health insurance, most people today when given a choice between a drug that costs pennies per dose that is safer and more effective, and a drug that is billed in the four-figures with lower efficacy and terrible side effects will take the MORE EXPENSIVE DRUG just because people operate on the premise that if a drug is more expensive, that it MUST be “better”. And besides, who cares? It gets billed to the insurance or to the government, so TOTALLY go with the more expensive “better” drug. It is a textbook example of an inverted price curve – aka “conspicuous consumption”.

NonVeni Mark is all over this. If you aren’t checking NonVeniPacem blog daily, you’re missing out. Remember, it was NonVeni Mark who essentially broke into the blogosphere the story that all attempted Coronavirus vaccines were poisonous and resulted in Antibody Dependent Enhancement and turned simple colds lethal when encountered post-vaccination. Here’s that link – check the date, folks: July 24, ARSH 2020. -AB

Now, here is the thread from @NC_updipchick

THREAD: Stick with me, I promise it’ll be worth it.

On Wednesday @RMConservativehad Dr. Paul Marik on his podcast to talk about Dr. Marik’s lawsuit against his employer, Sentara Healthcare. Basically, Sentara has told Dr. Marik that he is no longer permitted to treat patients With the MATH+ Protocol that he (along with hundreds of other doctors) has adopted to treat hospitalized COVID patients. In the course of the interview Dr. Marik mentioned that none of the cheaper drugs in his protocol came with a “bonus” so they weren’t appealing to the hospital. Naturally, this “bonus” caught my attention. Why would any COVID treatment be accompanied with a bonus? Sounds pretty unethical, right? So I asked Uncle Google and sure enough, I come across an article saying that hospitals can receive an extra 20% bonus for using remdesivir to treat COVID patients. Now I know that a 10 day cycle of remdesivir costs $3000 so I wasn’t too impressed with that $600 bonus. Not saying $600 is nothing, but it’s certainly not anything I’d be willing to go to court over. But then I kept reading. Here’s where it gets good…

Last November, when everyone was totally distracted with the election, the Centers for Medicare & Medicaid Services (CMS) updated its interim final rule with request for comments (IFC) and added a little noticed incentive for hospitals to treat with remdesivir Hospitals that provide proof of a positive PCR COVID test, who treat with 1 of the 2 drugs that have received EUA from the FDA for inpatient treatment of COVID, not only receive the 20% “new technology” bonus, they also qualify for a whole new system of billing.

Normally under Medicaid, hospitals are required to eat the first $30,000 in charges and then Medicaid picks up 80% of everything over that. So if a hospital billed $100,000 Medicaid would pay 80% of $70,000 or $56,000.

But after last November’s IFC, if a patient is Covid positive and is treated with remdesivir, Medicaid will cover 65% of that first $30,000. Which means that $56,000 reimbursement on the 100k bill is now a $75,500 reimbursement.

So that $600 bonus, is actually a $20,000 bonus. Per patient. Just so long as they’re treated with remdesivir. Starting to make sense now?

I couldn’t for the life of me figure out why these hospitals were denying dying patients the chance to try something that might work or taking their doctors to court to stop effective treatments. But in the end, it’s all about money. We’ve always known that.

Here are the links:

https://cms.gov/files/document/covid-vax-ifc-4.pdf…

Summary from the Health Care Compliance Association

jdsupra.com

CMS Hikes Payment for COVID-19 Inpatients Treated With New Drugs, Links it to 20% Bonus

Report on Medicare Compliance 29, no. 39 (November 2, 2020)

Article.

4 posts - 4 participants